These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 11359904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P.
    J Biol Chem; 2000 Aug 11; 275(32):24357-66. PubMed ID: 10823821
    [Abstract] [Full Text] [Related]

  • 3. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T.
    Lab Invest; 2003 Jul 11; 83(7):1033-43. PubMed ID: 12861043
    [Abstract] [Full Text] [Related]

  • 4. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
    Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker EB, Krammer PH, Walczak H.
    Cancer Res; 2000 Feb 01; 60(3):553-9. PubMed ID: 10676636
    [Abstract] [Full Text] [Related]

  • 5. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 01; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 6. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.
    Jönsson G, Paulie S, Grandien A.
    Anticancer Res; 2003 Jul 01; 23(2B):1213-8. PubMed ID: 12820373
    [Abstract] [Full Text] [Related]

  • 7. cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells.
    Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B.
    Diabetes; 2002 Jun 01; 51(6):1805-14. PubMed ID: 12031968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.
    Wachter T, Sprick M, Hausmann D, Kerstan A, McPherson K, Stassi G, Bröcker EB, Walczak H, Leverkus M.
    J Biol Chem; 2004 Dec 17; 279(51):52824-34. PubMed ID: 15459191
    [Abstract] [Full Text] [Related]

  • 10. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
    Zhang L, Blackwell K, Workman LM, Chen S, Pope MR, Janz S, Habelhah H.
    Mol Cell Biol; 2015 Oct 17; 35(19):3324-38. PubMed ID: 26195820
    [Abstract] [Full Text] [Related]

  • 11. TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
    Seol JY, Mihich E, Berleth ES.
    Cytokine; 2015 Oct 17; 75(2):321-9. PubMed ID: 26198031
    [Abstract] [Full Text] [Related]

  • 12. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
    Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M.
    Oncogene; 2001 Jun 28; 20(29):3888-96. PubMed ID: 11439352
    [Abstract] [Full Text] [Related]

  • 13. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L, Dittmer MR, Blackwell K, Workman LM, Hostager B, Habelhah H.
    Cell Signal; 2015 Feb 28; 27(2):306-14. PubMed ID: 25446254
    [Abstract] [Full Text] [Related]

  • 14. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gélinas C, Fuchs EJ, Bedi A.
    Nat Cell Biol; 2001 Apr 28; 3(4):409-16. PubMed ID: 11283615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA.
    Hepatology; 2002 Dec 28; 36(6):1498-508. PubMed ID: 12447876
    [Abstract] [Full Text] [Related]

  • 19. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ.
    J Invest Dermatol; 2001 Oct 28; 117(4):898-907. PubMed ID: 11676830
    [Abstract] [Full Text] [Related]

  • 20. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
    Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M.
    J Invest Dermatol; 2008 May 28; 128(5):1134-47. PubMed ID: 17989734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.